![Rafael Viñoly Architects | Novartis Pharmaceuticals Corporation, Edificio 337 - Rafael Viñoly Architects Rafael Viñoly Architects | Novartis Pharmaceuticals Corporation, Edificio 337 - Rafael Viñoly Architects](https://vinoly.com/wp-content/uploads/2016/05/Novartis_7-1778x1000.jpg)
Rafael Viñoly Architects | Novartis Pharmaceuticals Corporation, Edificio 337 - Rafael Viñoly Architects
![Novartis, already trialing hydroxychloroquine and Jakafi, plans COVID-19 testing for Ilaris | Fierce Pharma Novartis, already trialing hydroxychloroquine and Jakafi, plans COVID-19 testing for Ilaris | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1588087655/7263-Novartis%20Building.jpg/7263-Novartis%20Building.jpg?VersionId=4xdopDqVfWkTvodfZ75CIV4pOkWkl_9i)
Novartis, already trialing hydroxychloroquine and Jakafi, plans COVID-19 testing for Ilaris | Fierce Pharma
![Rafael Viñoly Architects | Novartis Pharmaceuticals Corporation, Edificio 337 - Rafael Viñoly Architects Rafael Viñoly Architects | Novartis Pharmaceuticals Corporation, Edificio 337 - Rafael Viñoly Architects](https://vinoly.com/wp-content/uploads/2016/05/Novartis_3-714x1000.jpg)
Rafael Viñoly Architects | Novartis Pharmaceuticals Corporation, Edificio 337 - Rafael Viñoly Architects
![Office, Mixed-Use Project: Novartis East Hanover Campus Transformation | 2015-03-11 | ENR | Engineering News-Record Office, Mixed-Use Project: Novartis East Hanover Campus Transformation | 2015-03-11 | ENR | Engineering News-Record](https://www.enr.com/ext/resources/archives/buildings/building_types/2015/extras/0316g/2.jpg)